Bacitracin Zinc Ointment USP
- Manufacturer
- E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc.
- Effective date
- 2014-08-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:27:54
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredient (in each gram):
Bacitracin Zinc (equal to 500 bacitracin units)
Purpose:
Antibiotic
INDICATIONS & USAGE SECTION
Uses:
first aid to help prevent infection in
- minor cuts
- scrapes
- burns
WARNINGS SECTION
Warnings: For external use only
Do not use
- in the eyes
- over large areas of the body
- if you are allergic to any of the ingredients
Ask doctor before use in case of deep or puncture wounds, animal bites or serious burns
When using this product do not use longer than 1 week unless directed by a doctor
Stop use and ask a doctor if
- the condition persists or gets worse
- if a rash or other allergic reaction develops
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions:
- clean the affected area
- apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
- may be covered with a sterile bandage
SPL UNCLASSIFIED SECTION
Other information:
- do not use if seal is punctured or is not visible. To open, reverse cap to puncture seal
- store at room temperature
- see crimp of tube for Lot Number and Exp. Date
Inactive Ingredients
white petrolatum
SPL UNCLASSIFIED SECTION
Questions or comments? call toll free 1-800-645-9833
E. FOUGERA & CO.
A division of Fougera Pharmaceuticals Inc.
Melville, NY 11747
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 4 Oz CONTAINER
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 4 Oz Carton
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 1/32 Oz CONTAINER
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – FOILPAC CARRIER CARTON
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 1 lb jar CONTAINER
FDA-Initiated Inactive NDC Indexing#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0168-0011-04 | GM - Gram | 0168-0011 | 4183200d-0ee7-44ec-a61d-ccb0d96daa26 | 1 | 2012-07-24 |
| 0168-0011-16 | GM - Gram | 0168-0011 | aa72cf65-9ace-4b68-8623-723b2ad7296f | 1 | 2012-07-24 |
| 0168-0011-31 | GM - Gram | 0168-0011 | 663eb974-383e-42dd-a023-a6f3912a99ed | 1 | 2012-07-24 |
| 0168-0011-35 | GM - Gram | 0168-0011 | b803f724-f27a-4037-8869-cb8b8f139d2e | 1 | 2012-07-24 |
| 0168-0111-09 | EA - Each | 0168-0111 | 879f2350-c3da-4ab7-9bbf-d53da491a81e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BACITRACIN ZINC | ACTIVE INGREDIENT | 89Y4M234ES | 2 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | 2 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 2 |
Products#
Every source-derived product name is available through these pages.
- Bacitracin Zinc
- BACITRACIN
- PETROLATUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0168-0011 | 0168-0011-35, 0168-0011-31, 0168-0011-04, 0168-0011-16 |
| 0168-0111 | 0168-0111-09 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BACITRACIN ZINC | 89Y4M234ES | ACTIM |
| PETROLATUM | 4T6H12BN9U | IACT |
| BACITRACIN ZINC | 89Y4M234ES | ACTIM |
| PETROLATUM | 4T6H12BN9U | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b558e3e0-70d8-440b-8833-8719b77f4325 | 41810930-aa84-4ab4-9df6-0afb1706a25b | 2021-09-22 | Warnings | 41810930-aa84-4ab4-9df6-0afb1706a25b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




